Ask AI
ProCE Banner Events

Share

When Blood Pressure Just Won’t Budge: Aldosterone and Hard-to-Control Hypertension From Mechanism to Management

Resistant hypertension contributes to high rates of cardiovascular events, stroke, and end-organ damage. Join our expert faculty as they examine the role of new aldosterone-targeting therapies with patient cases in this interactive workshop.

This event is not part of the official AHA Hypertension 2026 as planned by the AHA Committee on Hypertension Programming. 

Physicians: maximum of 1.50 AMA PRA Category 1 Credits

Physician Assistants/Physician Associates: 1.50 AAPA Category 1 CME credits

Nurse Practitioners/Nurses: 1.50 Nursing contact hours

Who Should Attend

This activity is intended for cardiology physicians, nurse practitioners, and physician associates, and other HCPs involved in the care of patients with hard-to-control hypertension. 

Time and location

Thursday, October 08, 2026

6:30 PM - 8:30 PM Eastern Time (ET)

In-person

7:00 PM - 8:30 PM Eastern Time (ET)

Virtual

Hyatt Regency Crystal City
2799 Richmond Hwy
Arlington, Virginia 22202

Agenda

Welcome and Opening Remarks

Aldosterone Excess as a Key Pathophysiologic Driver of Residual Risk

Translating Emerging Evidence Into Practice: Aldosterone-Targeted Therapies

Raise The Bar: Optimizing Care in Hard-to-Control Hypertension

Postassessment and Evaluation

Questions and Answers

Location

Venue Name

Hyatt Regency Crystal City

Address

Hyatt Regency Crystal City
2799 Richmond Hwy
Arlington, Virginia 22202

CME/CE Info

Goal Statement
The goal of this activity is to improve clinician practice in the identification and management of hard-to-control hypertension by promoting evidence-based evaluation of aldosterone excess and informed integration of emerging therapeutic strategies to reduce cardiovascular and kidney risk.

Target Audience
This activity is intended for cardiology physicians, nurse practitioners, and physician associates, and other HCPs involved in the care of patients with hard-to-control hypertension. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify the prevalence and clinical implications of hard-to-control hypertension among patients in clinical practice who remain above blood pressure goals despite antihypertensive treatment to support timely recognition and reassessment of management

  • Evaluate the pathophysiologic role of aldosterone excess in driving cardiovascular and kidney morbidity among patients with hard-to-control hypertension to inform clinical assessment and decision-making

  • Integrate current clinical evidence for novel and emerging aldosterone-targeted therapies into patient management decisions to optimize outcomes in patients with hard-to-control hypertension

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hours.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

IPCE Credit Designation

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/657115052be04.jpg

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporter

Supported by an educational grant from AstraZeneca.

AstraZeneca

Contact Information

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191

 

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.